Učitavanje...
Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis
Pulmonary sarcoidosis is characterized by an exaggerated CD4(+) T cell response and formation of non‐necrotizing granulomas. Tumour necrosis factor α (TNF‐α) is regarded as crucial for granuloma formation and TNF‐α inhibitors offer a third‐line treatment option for patients not responding to convent...
Spremljeno u:
| Izdano u: | Clin Exp Immunol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7290087/ https://ncbi.nlm.nih.gov/pubmed/32275772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13438 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|